Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16097300 | 0.87 | MAPT (0.36) | NPC1SMN1; SMN2 | |
| SCHEMBL17499540 | 0.87 | MEN1 (0.32) | NPC1 | |
| SCHEMBL16096383 | 0.86 | CA2 (0.30) | — | |
| SCHEMBL17499438 | 0.84 | NPSR1 (0.31) | NPSR1NPC1TP53PKMRAB9A | |
| SCHEMBL17499180 | 0.81 | MEN1 (0.30) | — | |
| SCHEMBL17499610 | 0.80 | KDM1A (0.33) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17499315 | 0.78 | SMN1; SMN2 (0.35) | NPSR1NPC1TP53PKMRAB9A | |
| SCHEMBL17499318 | 0.78 | SMN1; SMN2 (0.35) | NPSR1NPC1TP53PKMRAB9A | |
| SCHEMBL16097302 | 0.78 | ACHE (0.35) | NPSR1SMN1; SMN2 | |
| SCHEMBL16096309 | 0.78 | KDM1A (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2969593-B1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC IMINES | BRIDGESTONE CORP (JP) | 2020-11-04 | — | — | EP | disclosed |
| US-9850328-B2 | Polymers functionalized with heterocyclic imines | BRIDGESTONE CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| US-20160039958-A1 | Polymers Functionalized With Heterocyclic Imines | BRIDGESTONE CORPORATION (JP) | 2016-02-11 | — | — | US | disclosed |